# Dosimetry Guided PRRT With 90Y-DOTATOC

> **NCT03013387** · PHASE2 · WITHDRAWN · sponsor: **Sue O'Dorisio**

## Conditions studied

- Neuroendrocrine Tumors
- Meningioma
- Neuroblastoma
- Medulloblastoma

## Interventions

- **RADIATION:** 90Y-DOTA-3-tyr-Octreotide
- **PROCEDURE:** Positron Emission Tomography (PET) whole body scan
- **DRUG:** Amino Acids

## Key facts

- **NCT ID:** NCT03013387
- **Lead sponsor:** Sue O'Dorisio
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-01
- **Primary completion:** 2018-10
- **Final completion:** 2019-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This project has undergone a significant amount of updates and has been resubmitted under IRB# 201708778
- **Last updated:** 2017-08-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03013387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03013387, "Dosimetry Guided PRRT With 90Y-DOTATOC". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03013387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*